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Chlorhexidine (CHX) is recognized as the primary agcnt for chemical plaque
Control (Jones, 1997).1t can be used in mouthrinses and gels (Cummins and Creeth, 1992).
Mouthrinse formulations are effective in reducing gingivitis (Grossman et a!., 1986) and
g~ISare potent chemotherapeutic agents against mutans streptococci and caries (Emilson,
1994). The maj 01' ad vantage of CHX over most other compounds Iies in its oral substanti vity
CAdams and Addy, 1994), because it is a cationic substance that binds to soft and hard
ll5S ues of the mouth (Rolla and Melsen, 1975) as well as to bacterial cell walls (Jones,
Braz Dent J (2000) 11(1): 29-34 ISSN 0103-6440
Effect of Saccharin on Antibacterial Activity of
Chlorhexidine Gel
Jaime Aparecido CURY'
Eduardo Passos ROCHN
Hyun KOO'
Silvana Boldrini FRANCISCO I
Altair Antoninha DEL BEL CURy2
JLaboratório de Bioquímica Oral
2Deparlamento de Protese e Periodontia
Faculdade de Odontologia de Piracicaba, UNICAMP, Piracicaba, SP, Brasil
Although chlorhexidine is the most effective agent against dental plaque it is extremely bitter.
To prepare formulations, it is necessary to use flavoring and sweetening, which can inhibit the
antibacterial effect of chlorhexidine. Saccharin has been considered a cornpatible substance to use in
chlorhexidine rinse or gel preparations; however, the effect of a range of concentrations has not been
studied. To evaluate the effect of different concentrations of saccharin on the antibacterial activity of
chlorhexidine gel, hydroxy-ethyl-cellulose gels containing 1.0% chlorhexidine digluconate and 0.0
to 1.0% sodium saccharin were prepared. Activity against Streptococcus mutans was evaluated using
the agar diffusion method and deterrnination of MIC values. The inhibitory zones of growth were
7.83 ± 0.54 mrn when no saccharin was added to the chlorhexidine gel and 7.75 ± 0.50,7.63 ± 0.48,
6.21 ± 0.40, 4.13 ± 0.38, when the concentrations of saccharin in the gels were 0.02, 0.10, 0.5, and
1.0%, respectively. The range of MIC values was 1-2 ug/rnl, with saccharin concentrations 01' 0%,
0.02, and 0.1 %. In contrast, the M IC values were 4-8 and 8-16 ug/rnl with saccharin concentrations
01' 0.5% and 1.0%, respectively. The paired "r" test showed that 0.5 and 1.0% sodiurn saccharin
inhibit the antibacterial activity of 1% digluconate chlorhexidine gel. These in vitro results suggest
that saccharin may inhibit the efficacy of chlorhexidine against rnutans streptococci, depending on
the concenrration.
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1997). However, when formulations are prepared the availability ofCHX can be impaired.
While dentifrices are considered inappropriate vehic\es to deliver CHX because of the
detrimental interactions between CHX and the foarning and abrasive agents used (van der
Ouderaa and Cumrnins, 1989), mouthrinses and gels are considered compatible (van der
Ouderaa, 1991).
Because CHX has an extremely bitter taste, it is often necessary to flavor and
sweeten mouthrinses and gel products. Saccharin is considered compatible with CHX (van
der Bijl and Dreyer, 1982) and has been used in gel preparations (Ostela et aI., 1990;
Tenovuo et aI., 1992). However, when a 1% CHX gel regime suggested by Maltz et aI.
(1981) was applied in volunteers using removable dentures we were not able to show
salivary mutans streptococci reduction (Rocha et aI., 1999). Our explanation was that the in
vivo antibacterial activity ofCHX was inhibited by saccharin added to improve the taste of
the gel. Considering that saccharin has not been recognized as a substance incompatible
with CHX (Gardner and Gray, 1983), we decided to test the hypothesis that this inhibition
could be an effect of concentration.
Material and Methods
The antibacterial activity was evaluated by the agar diffusion method using brain
heart infusion (BHI, Difco, Detroit, MI, USA) and Mueller Hinton (Difco) agars. The
microorganism was seeded by pour plate. Streptococcus mutans Ingbritt 1600 (kindly
donated by Eastrnan Dental Center, Rochester, NY, USA) actively growing in BHI broth
was subcultured onto BHI agar plates (100 x 20 rnrn) for 18-24 h at 37°C in a 10% CO2
environment (IG 150 incubator, Jouan S.A., Saint-Herblain, France). Isolated colonies
were suspended in 5.0 ml 01' sterile 0.85% NaCI solution, homogenized in a vortex mixer
and the suspension was adjusted spectrophotometrically to match 0.5 ofturbidity according
to the McFarland standard. A volume 01'0.5 ml was mixed with 50 ml BHI agar at 45°C and
poured onto a Petri dish (150 x 25 mm) containing a previous set layer of MH agar. The
inoculum proced ure was appropriate to provide a semi-confl uent bacterial growth (Phillips,
1991). To evaluate the CHX gel antibacterial activity, 5 sterile stainless cylinders (8.0 x
10.0 mrn) were placed onto each inoculated agar plate. The cylinders were filled with 1%
CHX gels (pharmacy prepared, containing 1.0 g chlorhexidine digluconate (Medichern SA,
Spain); 1.0 g hydroxy-ethyl-cellulose 250 (Galena Química e Farmacêutica Ltda, Camp+
nas, SP, Brazil); 0.0, 0.02, 0.1, 0.5 or 1.0 g sodium saccharin (KD Feddersen & Co,
Gerrnany), and deionized water to 100 g). The plates were incubated at 37°C for 24 h in an
incubatorcontaining 10% C02and the zones ofgrowth inhibition around the cylinders were
measured using a digital caliber rule (± 0.01 mrn).
For statistical analysis, 6 replicates were made and the inhibitory zones, in mm, were
evaluated by paired "t" test at p<0.05. In order to check if the gel formulation affected the
diffusibility ofthe active agent (CHX), ali of these preparations were also diluted in sterde
deionized water to reach O. I 2% of CHX and tested for antibacterial activity following the
same procedures described above. An aliquot 01' 100 111of the preparation was added to
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stainless cylinders and incubated as previously described. Chlorhexidine digluconate (C-
9394, Sigma Chemical Co., St. Louis, MO, USA) diluted to O. 12% was used as a positive
control.
In addition, the minimum inhibitory concentration (MIC) of diluted CHX gel
preparations was determined. The assay concentration of S. mutans was I -2 x 105 colony
forming units/ml (CFU/ml) (Barry et aI., 1983; Phillips, 1991). Tubes containing BHI broth
inoculum and a two-fold dilution series ofCHX formulations (concentrations ranging from
0.25 to 16 I1g of CHX/ml) were incubated at 37°C, 10% COl> for 24 h. After incubation,
bacterial growth was assayed spectrophotometrically by measurement of absorbance at 660
nm (A6Go), MIC was defined as the lowest concentration of CHX that restricted growth to
a levei <0.05 A660 (no visible growth). Six replicates were made for each analysis.
Results and Discussion
The values of inhibitory zones are shown in Table 1. At concentrations of 0.02 or
0.1 %, saccharin did not significantly inhibit the antibacterial activity of 1% CHX gel.
However, at concentrations of 0.5 and 1% saccharin significantly reduced (p<0.05) the
anti-mutans activity of 1% CHX gel, as demonstrated by the smaller inhibitory zones. These
data were confirmed by analyzing the MIC values (Table 2). The addition of 0.5% and 1%
saccharin reduced the antibacterial activity 4-8 and 8-16 times, respectively, when com-
pared to the CHX standard (Sigma), whereas 0.02 and 0.1 % saccharin did not significantly
affect the anti-mutans activity of CHX. The range ofMIC values (1-2I1g/ml) obtained for
CHX standard (Sigma) is in agreement with previous studies (Osawa et aI., 1992; Jãrvinen
et aI., 1993; Drake et aI., 1993). Therefore, these results demonstrate that depending on the
Table I - Means (± SD) of the inhibitory zone of S. mutans lngbritt 1600 growth according to the
formulations evaluated.
Formulations lnhibitory zone (mm)
Gel preparation
Inhibitory zone (mm)
Diluted gel*
I%CHX
1%CHX + 0.02% Saccharin
1% CHX + 0.1% Saccharin
1%CHX + 0.5% Saccharin
1%CHX + 1.0% Saccharin
7.83 ± 0.54a
7.75 ± 0.50a
7.63 ± 0.48a
6.21 ± 0.40;'
4.13 ±0.38"
6.50 ± 0.30"
6.42 ± 0.29"
6.33 ± 0.25"
5.00 ± 0.30b
3.25 ± 0.26"
---------------------------------------------------------------------
*The gel preparations were diluted in sterile deionized water to reach a concentration 01'0.12% CHX.
The inhibitory zone of bacterial growth of CHX standard (Sigma) at a concentration of 0.12% was
6.54 ± 0.26.
Different superscript letters indicate statistically significant differences (p<0.05) among the
fonnulations.
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concentration, saccharin can inhibit
CHX antibacterial activity in vitro,
These data explain our previous in
vivo study when we were not able to
show reduced mutans streptococci
when 1% CHX gel containing 1% sac-
charin was used (Rocha et al., 1999).
The present in vitro evaluation
supports the observations of van der
Bijl and Dreyer (1982) who prepared
a mouthrinse containing 0.2% CHX
and 0.0 I% saccharin, in combination
with 0.1 % cyclamate to improve its
taste. If saccharin had been the only
sweetener added at a higher concen-
tration, CHX may have been inhibited.
The results also support the observa-
tions of Ostela et al. (1990) and Tenovuo et aI. (1992) who reported a reduction 01' salivary
mutans streptococci when 1% CHX gel containing 0.02% saccharin was applied in
volunteers.
The sweetness acceptability of a therapeutic product may be variable depending on
regional and cultural differences. In Brazil, most oral hygiene products contain 0.2 to 1%
saccharin. Particularly for CHX gel forrnulations, 1% saccharin is added to make the gel
acceptable. Therefore, when saccharin is used, the detrimental effect of concentration on
CHX activity should be considered or another non-complexing sweetener should be used.
When we repeated our previous study using CHX gel containing aspartame as sweetener
there was a reduction in salivary mutans streptococci in volunteers using removable
dentures (Rocha et al., 1999).
The results of this in vitro study c1early showed that, depending on the concentra-
tion, saccharin inhibits the antibacterial activity of CHX. It is more difficult to understand
this inhibition because the concentrations are in percentage. However, considering that in
the gel containing 1% chlorhexidine digluconate and 1% sodium saccharin there were 10
millimoles 01' CHX for 46 millimoles 01' saccharin, it is easier to understand the inhibition.
This can be explained by stoichiometric binding of CHX by saccharin (Sac) according to
the equilibrium:
Table 2 - The range 01' MIC values 01' different
formulations 01' CHX for S. inutans Ingbritt 1600.
Formulations Range ofMIC
values (ug/rnl)"
I%CHX
1% CHX + 0.02% Saccharin
1% CHX + 0.1 % Saccharin
1% CHX + 0.5% Saccharin
1% CHX + 1.0% Saccharin
1-2
1-2
1-2
4-8
8-16
*Two-fold dilution series of CHX fonnulations at
concentrations ranging from 0.25 to 16 ug 01' CHX/ml.
The range 01' MIC values 01' CHX standard (Sigrna)
was 1-2 ug/ml.
K=------
[CHX] [SacF
CHX2++ 2Sac CHX(Sac)2
In fact, the data suggested that insoluble salts [CHX(Sach] were formed between
CHX and saccharin which may be through an interaction between the positively charged
groups ofCHX and the sulfonyl group ofsaccharin. Precipitated insoluble products were
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observed when the gel formulations were suspended in water. It was possible to note that the
1% CHX gel containing 0.5 and 1% of saccharin are cloudy while the gel without saccharin
is c1ear. Even the gel containing 0.1 % of saccharin is not totally transparent, but the CHX
available still showed a significant antibacterial activity. There is a precedence for this in
the literature; zinc, a well-known antibacterial agent can be complexed by saccharin
(Christie et al., 1991).
In conclusion, these in vitro data suggest that depending on the concentration of
saccharin used to make CHX acceptable, the in vivo antibacterial activity ofthis CHX may
be reduced.
Resumo
Cury JA, Rocha EP, Koo H, Francisco S8, DeI 8el Cury AA: Efeito da sacarina na atividade
antibacteriana da clorexidina. Braz Dent J 11 CI): 29-34,2000.
Embora clorexidina seja reconhecida como o agente antimicrobiano mais eficiente contra placa
dental, seu gosto extremamente amargo é uma limitação nos preparos farmacêuticos. Substâncias
adoçantes e tlavorizantes usadas para preparar formulações podem inibir a atividade antibacteriana
da c1orexidina. Sacarina tem sido considerada uma substância compatível para ser usada em
enxaguatórios bucais ou géis, entretanto o efeito da concentração deste adoçante não tem sido
estudado. A atividade antibacteriana de géis de clorexidina a I%, contendo sacarina de 0,0 a 1,0%,
foi avaliada a partir de preparações farmacêuticas formuladas. Atividade contra Streptococcus
IlllllaJ:S foi ~valiada através da inibiç.ão do crescimento em ágar e determinação da concentração
I 111bitória muurna CCIM). OS halos de inibição de crescimento foram de 7,83 ± 0,54 mm, na ausência
de sacarina, e de 7,75 ± 0,50, 7,63 ± 0,48, 6,21 ± 0,40 e 4, 13 ± 0,38 quando da presença de sacarina
a 0,02, 0,10,0,5 e I%, respectivamente, nos géis de clorexidina a I%. A faixa de CIM foi de 1-2 flgl
ml quando da presença de 0,0,0,02 e O, I% de sacarina nos géis. Quando o gel de clorexidina a 1%
continha sacarina a 0,5 e I% a CIM foi de 4-8 e 8-16 ug/rnl, respectivamente. Teste "t" pareado
mostrou que sacarina sódica nas concentrações de 0,5 e I% inibiu a atividade anti mutans de
diglu~onato de clorexidina a I% em gel. Estes resultados in vitro sugerem que sacarina pode inibir
a eficácia de clorexidina contra streptococcus do grupo mutans, dependendo da concentração usada.
Unitermos: clorexidina, sacarina, Streptococcus mutans, placa dental, antimicrobianos.
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